Form 4 for IMRX Immuneering Corp
Accepted 2025-10-02 00:00:00 ET · period of report 2025-10-01 · accession 0001790340-25-000121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-02 | 2025-10-01 | IMRX | Bookman Michael | CLO, Sec | P - Purchase | $6.83 | +1,020 | 4,870 | +26% | +$6,967 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-10-01 | P | A | 1,020 | $6.83 | 4,870 | D | — | — |